Shahida Moosa

Shahida Moosa

Auto-generated profile, based on publicly available information

Shahida Moosa

Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
THTzung-Chien Hsieh
Tzung-Chien Hsieh
ABAviram Bar-Haim
Aviram Bar-Haim
SMShahida Moosa
Shahida Moosa
NENadja Ehmke
Nadja Ehmke
KGKaren W. Gripp
Karen W. Gripp
PKPeter M. Krawitz
Peter M. Krawitz
Many monogenic disorders cause a characteristic facial morphology. Artificial intelligence can support physicians in recognizing these patterns by associating facial phenotypes with the underlying syndrome through training on thousands of patient photographs. However, this ‘supervised’ approach means that diagnoses are only possible if the disorder was part of the training set. To improve recognition of ultra-rare disorders, we developed GestaltMatcher, an encoder for portraits that is based on a deep convolutional neural network. Photographs of 17,560 patients with 1,115 rare disorders were used to define a Clinical Face Phenotype Space, in which distances between cases define syndromic similarity. Here we show that patients can be matched to others with the same molecular diagnosis even when the disorder was not included in the training set. Together with mutation data, GestaltMatcher could not only accelerate the clinical diagnosis of patients with ultra-rare disorders and facial dysmorphism but also enable the delineation of new phenotypes.

22 July 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ASAxel Schmidt
Axel Schmidt
MDMagdalena Danyel
Magdalena Danyel
KGKathrin Grundmann
Kathrin Grundmann
TBTheresa Brunet
Theresa Brunet
HKHannah Klinkhammer
Hannah Klinkhammer
MWMatias Wagner
Matias Wagner
Individuals with ultrarare disorders pose a structural challenge for healthcare systems since expert clinical knowledge is required to establish diagnoses. In TRANSLATE NAMSE, a 3-year prospective study, we evaluated a novel diagnostic concept based on multidisciplinary expertise in Germany. Here we present the systematic investigation of the phenotypic and molecular genetic data of 1,577 patients who had undergone exome sequencing and were partially analyzed with next-generation phenotyping approaches. Molecular genetic diagnoses were established in 32% of the patients totaling 370 distinct molecular genetic causes, most with prevalence below 1:50,000. During the diagnostic process, 34 novel and 23 candidate genotype–phenotype associations were identified, mainly in individuals with neurodevelopmental disorders. Sequencing data of the subcohort that consented to computer-assisted analysis of their facial images with GestaltMatcher could be prioritized more efficiently compared with approaches based solely on clinical features and molecular scores. Our study demonstrates the synergy of using next-generation sequencing and phenotyping for diagnosing ultrarare diseases in routine healthcare and discovering novel etiologies by multidisciplinary teams.

1 October 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SMShahida Moosa
Shahida Moosa
GYGuilherme L. Yamamoto
Guilherme L. Yamamoto
LGLutz Garbes
Lutz Garbes
KKKatharina Keupp
Katharina Keupp
ABAna Beleza-Meireles
Ana Beleza-Meireles
CNChristian Netzer
Christian Netzer

1 November 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
Muhammad Sajid HussainMuhammad Sajid Hussain
Muhammad Sajid Hussain
ABAgatino Battaglia
Agatino Battaglia
SSSandra Szczepanski
Sandra Szczepanski
EKEmrah Kaygusuz
Emrah Kaygusuz
MTMohammad Reza Toliat
Mohammad Reza Toliat
PNPeter Nürnberg
Peter Nürnberg

1 May 2016 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
SMShahida Moosa
Shahida Moosa
BWBernd Wollnik
Bernd Wollnik

12 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
NLNajim Lahrouchi
Najim Lahrouchi
AGAman George
Aman George
IRIlham Ratbi
Ilham Ratbi
RSRonen Schneider
Ronen Schneider
SESiham C. Elalaoui
Siham C. Elalaoui
ASAbdelaziz Sefiani
Abdelaziz Sefiani
A failure in optic fissure fusion during development can lead to blinding malformations of the eye. Here, we report a syndrome characterized by facial dysmorphism, colobomatous microphthalmia, ptosis and syndactyly with or without nephropathy, associated with homozygous frameshift mutations in FAT1. We show that Fat1 knockout mice and zebrafish embryos homozygous for truncating fat1a mutations exhibit completely penetrant coloboma, recapitulating the most consistent developmental defect observed in affected individuals. In human retinal pigment epithelium (RPE) cells, the primary site for the fusion of optic fissure margins, FAT1 is localized at earliest cell-cell junctions, consistent with a role in facilitating optic fissure fusion during vertebrate eye development. Our findings establish FAT1 as a gene with pleiotropic effects in human, in that frameshift mutations cause a severe multi-system disorder whereas recessive missense mutations had been previously associated with isolated glomerulotubular nephropathy.